How to avoid warfarin’s polypharmacy dangers. Which non-AIDS conditions hint at HIV infection? How San Francisco delivers faster HIV treatment. And red meat may fuel the rise of fatty livers.

Stem cells could reverse premature menopause. The FDA wants to snuff out nicotine in cigarettes. The elusive "male pill" may be near. And teens with tanning addiction have other burning issues.

MedPAC takes its Medicare pay campaign to Congress, a gout drug has a puzzling link to cardiovascular deaths, chlamydia drives up ovarian cancer risk, and the envelopes are torn open on Match Day 2018.

Three regular meals a day are best for type 2 diabetes, surgery is more successful for adrenal cortical carcinoma, how thyroid-stimulating hormone affects infertility, and new practice guidelines on testosterone therapy make their debut.

Alcohol dependence ages your brain. Artificial intelligence comes to glucose monitoring. There’s a promising combo treatment for allergic rhinitis. And evidence mounts for the importance of thrombectomy in stroke.

Could gut bacteria trigger autoimmune diseases? Vouchers might improve post-heart-attack drug compliance. How education affects depression risks for women. And why confusion reigns over the COPD-asthma overlap.

How to have "The Talk" about medical marijuana, uniformity comes to inflammatory bowel disease severity, diabetes drives the nation’s drug bills, and there’s pushback against new blood sugar targets.

Closer tailoring might boost wearable cardioverter defibrillators' benefit, alirocumab cuts deaths in post-acute coronary syndrome patients, the ODYSSEY Outcomes trial redefines secondary cardiovascular prevention, and how walking cuts postmenopausal women's heart failure risk.

Is it time to raise the bar on diabetes blood sugar levels? Sudden cardiac death menaces young diabetes patients. There’s room for improvement in treating psoriatic arthritis. And the FDA chief chastises payers over high drug prices.